chronic lymphocytic leukemia
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
chronic lymphocytic leukemia
Jul 22, 2024, 07:05 |
Insight
Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial
Mazyar Shadman, Associate Professor of Medical Oncology at Fred Hutch Cancer Center, shared on X about…
Jul 8, 2024, 10:45 |
Blog
Treatment of Chronic Lymphocytic Leukemia and Richter's transformation - VJHemOnc
VJHemOnc shared a post on X: “Do not miss out on our recent session from…
Jul 1, 2024, 19:24 |
Insight
Léa Ikhlef: The use of extracellular vesicles as a communication tool by TAMS in CLL
Léa Ikhlef, Postdoctoral researcher at Léon Bérard Center, shared on LinkedIn: “I'm glad to share…
Jun 29, 2024, 16:57 |
Insight
MD Anderson Research Highlights: EHA 2024 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Jun 24, 2024, 02:19 |
Insight
Nitin Jain: Pirtobrutinib Venetoclax and Obinutuzumab in First-Line treatment for CLL
Nitin Jain shared on X: . "Delighted…
Jun 10, 2024, 16:08 |
Blog
It was great to catch up with Mazyar Shadman at ASCO24 - VJHemOnc
VJHemOnc shared a post on X: "It was great to catch up with Mazyar Shadman at…
Mar 19, 2024, 03:44 |
Drugs
Nitin Jain: The U.S. FDA approves lisocabtagene maraleucel for adults with relapsed or refractory CLL or SLL
Nitin Jain, The Director of the Leukemia CAR-T Program at the MD Anderson Cancer Center,…
Mar 17, 2024, 15:46 |
Blog
The first doses of a breakthrough treatment have been delivered to patients with chronic lymphocytic leukemia in Armenia and Nepal! - The Max Foundation
The Max Foundation made the following post on LinkedIn: "We have some amazing news today!…
All:
8
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube